Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients

Published:2007-11-30 Issue:9 Volume:67 Page:1343-1346
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Annals of the Rheumatic Diseases

Author:

Josselin L,Mahr A,Cohen P,Pagnoux C,Guaydier-Souquieres G,Hayem G,Job-Deslandre C,Liferman F,Pourrat J,Guillevin L

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rheumatoid vasculitis in 2023: Changes and challenges since the biologics era;Autoimmunity Reviews;2023-09

2. Update on Maintenance Therapies for ANCA-Associated Vasculitis;Current Treatment Options in Rheumatology;2021-04-29

3. Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy;Minerva Medica;2021-04

4. Tumor Necrosis Factor Inhibitors;Comprehensive Dermatologic Drug Therapy;2021

5. Biological therapy in rheumatoid vasculitis: a systematic review;Clinical Rheumatology;2020-10-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP